Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07640997
What this trial is testing

Real-world Study of Aflibercept 8 mg in nAMD

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Peking University People's Hospital 300
Testing effectiveness (Phase 2)Study completedNCT03423823
What this trial is testing

Ziv-aflibercept Efficacy in Better Regulating AMD

Who this might be right for
Wet Macular DegenerationWet Age-related Macular Degeneration
Kapil Kapoor 62
Not applicableStudy completedNCT01833325
What this trial is testing

Proton Radiation Therapy for Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University of Florida 9
Post-approval studies (Phase 4)Looking for participantsNCT07403825
What this trial is testing

Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

Who this might be right for
Macular Degeneration, Age Related
Biobizkaia Health Research Institute 100
Testing effectiveness (Phase 2)Looking for participantsNCT07275840
What this trial is testing

Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics Technology Limited (Shanghai R&D Center) 800
Testing effectiveness (Phase 2)Study completedNCT07501052
What this trial is testing

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Who this might be right for
Neovascular (Wet) Age-Related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema+1 more
Sam Chun Dang Pharm. Co. Ltd. 33
Testing effectiveness (Phase 2)Ended earlyNCT01362348
What this trial is testing

12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
GlaxoSmithKline 19
Testing effectiveness (Phase 2)Study completedNCT00574093
What this trial is testing

Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD

Who this might be right for
Neovascular Age Related Macular Degeneration
Fondazione G.B. Bietti, IRCCS 15
Not applicableStudy completedNCT05281042
What this trial is testing

Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Notal Vision Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00612456
What this trial is testing

To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD

Who this might be right for
Macular Degeneration
GlaxoSmithKline 70
Post-approval studies (Phase 4)Study completedNCT03169660
What this trial is testing

Intravitreal Aflibercept for Submacular Hemorrhage

Who this might be right for
Exudative Age-related Macular Degeneration
Kim's Eye Hospital 29
Testing effectiveness (Phase 2)UnknownNCT05390840
What this trial is testing

Investigate the Effect on Central Macular Thickness of Treatment With MG-O-1002 Eye Drops in Participants Aged Over 45 With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Age-Related Macular Degeneration
Theratocular Biotek Co. 36
Not applicableStudy completedNCT05678517
What this trial is testing

Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD

Who this might be right for
Age-Related Macular Degeneration
Semmelweis University 47
Large-scale testing (Phase 3)Study completedNCT03844074
What this trial is testing

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration
Outlook Therapeutics, Inc. 61
Very early researchStudy completedNCT00517010
What this trial is testing

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
University of California, Davis 6
Large-scale testing (Phase 3)Study completedNCT02462928
What this trial is testing

A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 939
Large-scale testing (Phase 3)Study completedNCT05569148
What this trial is testing

A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 35
Testing effectiveness (Phase 2)Looking for participantsNCT07205887
What this trial is testing

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Who this might be right for
Neovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO)
EyeBiotech Ltd. 160
Large-scale testing (Phase 3)Study completedNCT00021736
What this trial is testing

Phase II/III Study of Anti-VEGF in Neovascular AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Eyetech Pharmaceuticals 540
Early research (Phase 1)WithdrawnNCT00538538
What this trial is testing

Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)

Who this might be right for
Retinal HemorrhageMacular Degeneration
Corewell Health East
Next Page